Literature DB >> 26275365

Interval sentinel lymph nodes in melanoma: a digital pathology analysis of Ki67 expression and microvascular density.

Christian Marinaccio1, Giuseppe Giudice2, Eleonora Nacchiero2, Fabio Robusto3, Giuseppina Opinto4, Gaetano Lastilla4, Eugenio Maiorano4, Domenico Ribatti5,6.   

Abstract

The presence of interval sentinel lymph nodes in melanoma is documented in several studies, but controversies still exist about the management of these lymph nodes. In this study, an immunohistochemical evaluation of tumor cell proliferation and neo-angiogenesis has been performed with the aim of establishing a correlation between these two parameters between positive and negative interval sentinel lymph nodes. This retrospective study reviewed data of 23 patients diagnosed with melanoma. Bioptic specimens of interval sentinel lymph node were retrieved, and immunohistochemical reactions on tissue sections were performed using Ki67 as a marker of proliferation and CD31 as a blood vessel marker for the study of angiogenesis. The entire stained tissue sections for each case were digitized using Aperio Scanscope Cs whole-slide scanning platform and stored as high-resolution images. Image analysis was carried out on three selected fields of equal area using IHC Nuclear and Microvessel analysis algorithms to determine positive Ki67 nuclei and vessel number. Patients were divided into positive and negative interval sentinel lymph node groups, and the positive interval sentinel lymph node group was further divided into interval positive with micrometastasis and interval positive with macrometastasis subgroups. The analysis revealed a significant difference between positive and negative interval sentinel lymph nodes in the percentage of Ki67-positive nuclei and mean vessel number suggestive of an increased cellular proliferation and angiogenesis in positive interval sentinel lymph nodes. Further analysis in the interval positive lymph node group showed a significant difference between micro- and macrometastasis subgroups in the percentage of Ki67-positive nuclei and mean vessel number. Percentage of Ki67-positive nuclei was increased in the macrometastasis subgroup, while mean vessel number was increased in the micrometastasis subgroup. The results of this study suggest that the correlation between tumor cell proliferation and neo-angiogenesis in interval sentinel lymph nodes in melanoma could be used as a good predictive marker to distinguish interval positive sentinel lymph nodes with micrometastasis from interval positive lymph nodes with macrometastasis subgroups.

Entities:  

Keywords:  Angiogenesis; Interval lymph node; Melanoma; Metastasis; Tumor progression

Mesh:

Substances:

Year:  2015        PMID: 26275365     DOI: 10.1007/s10238-015-0379-9

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  55 in total

1.  Epitrochlear sentinel lymph nodes in melanoma: interval or independent?

Authors:  Travis B Kidner; Jeong L Yoon; Mark B Faries; Donald L Morton
Journal:  Am Surg       Date:  2012-06       Impact factor: 0.688

Review 2.  Regressing thin cutaneous malignant melanomas (< or = 1.0 mm) are associated with angiogenesis.

Authors:  R L Barnhill; M A Levy
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

3.  Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival.

Authors:  S Ugurel; G Rappl; W Tilgen; U Reinhold
Journal:  J Clin Oncol       Date:  2001-01-15       Impact factor: 44.544

4.  The impact of dynamic lymphoscintigraphy and gamma probe guidance on sentinel node biopsy in melanoma.

Authors:  R Pijpers; G J Collet; S Meijer; O S Hoekstra
Journal:  Eur J Nucl Med       Date:  1995-11

5.  Primary tumor induces sentinel lymph node lymphangiogenesis in oral squamous cell carcinoma.

Authors:  Hiroki Ishii; Kazuaki Chikamatsu; Koichi Sakakura; Masanori Miyata; Nobuhiko Furuya; Keisuke Masuyama
Journal:  Oral Oncol       Date:  2010-03-21       Impact factor: 5.337

6.  Increased sentinel lymph node lymphangiogenesis is associated with nonsentinel axillary lymph node involvement in breast cancer patients with a positive sentinel node.

Authors:  Gert G Van den Eynden; Melanie K Vandenberghe; Pieter-Jan H van Dam; Cecile G Colpaert; Peter van Dam; Luc Y Dirix; Peter B Vermeulen; Eric A Van Marck
Journal:  Clin Cancer Res       Date:  2007-09-15       Impact factor: 12.531

7.  Surgical management of aberrant sentinel lymph node drainage in cutaneous melanoma.

Authors:  K A Lieber; S B Standiford; B W Kuvshinoff; D M Ota
Journal:  Surgery       Date:  1998-10       Impact factor: 3.982

8.  Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI).

Authors:  Alessandro Testori; Gian Luca De Salvo; Maria Cristina Montesco; Giuseppe Trifirò; Simone Mocellin; Giorgio Landi; Giuseppe Macripò; Paolo Carcoforo; Giuseppe Ricotti; Giuseppe Giudice; Franco Picciotto; Davide Donner; Franco Di Filippo; Javier Soteldo; Dario Casara; Mauro Schiavon; Antonella Vecchiato; Sandro Pasquali; Federica Baldini; Giovanni Mazzarol; Carlo Riccardo Rossi
Journal:  Ann Surg Oncol       Date:  2009-01-09       Impact factor: 5.344

9.  Tumor cell plasticity and angiogenesis in human melanomas.

Authors:  Daniela Mihic-Probst; Kristian Ikenberg; Marianne Tinguely; Peter Schraml; Silvia Behnke; Burkhardt Seifert; Gianluca Civenni; Lukas Sommer; Holger Moch; Reinhard Dummer
Journal:  PLoS One       Date:  2012-03-19       Impact factor: 3.240

10.  Vascularity in cutaneous melanoma detected by Doppler sonography and histology: correlation with tumour behaviour.

Authors:  A Srivastava; L E Hughes; J P Woodcock; P Laidler
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640

View more
  1 in total

Review 1.  Next-Generation Digital Histopathology of the Tumor Microenvironment.

Authors:  Felicitas Mungenast; Achala Fernando; Robert Nica; Bogdan Boghiu; Bianca Lungu; Jyotsna Batra; Rupert C Ecker
Journal:  Genes (Basel)       Date:  2021-04-07       Impact factor: 4.096

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.